Table 3 Univariate analysis predicting all cause and cardiovascular disease mortality
PatientsnPerson time intervalsAll cause mortalityCVD mortality
Univariate, OR (95% CI)Adjusted age and gender, OR (95% CI)Univariate, OR (95% CI)Adjusted age and gender, OR (95% CI)
Baseline NSAID useAll92356340.73 (0.55 to 0.99)0.81 (0.60 to 1.03)0.67 (0.43 to 1.04)0.73 (0.48 to 1.15)
Females59937420.86 (0.56 to 1.32)0.86 (0.55 to 1.32)0.55 (0.30 to 1.02)0.54 (0.29 to 1.02)
Males32418920.61 (0.41 to 0.92)0.74 (0.50 to 1.12)0.79 (0.42 to 1.47)0.94 (0.50 to 1.78)
Ever NSAID useAll92356340.62 (0.44 to 0.86)0.70 (0.50 to 1.00)0.48 (0.29 to 0.77)0.54 (0.33 to 0.88)
Females59937420.74 (0.44 to 1.22)0.81 (0.48 to 1.36)0.42 (0.22 to 0.82)0.46 (0.23 to 0.90)
Males32418920.49 (0.31 to 0.77)0.61 (0.39 to 0.98)0.50 (0.25 to 1.01)0.62 (0.31 to 1.27)
Time-varying NSAID useAll92356340.58 (0.43 to 0.78)0.66 (0.49 to 0.90)0.51 (0.32 to 0.81)0.58 (0.37 to 0.93)
Females59937420.60 (0.39 to 0.91)0.68 (0.44 to 1.05)0.50 (0.26 to 0.97)0.58 (0.30 to 1.12)
Males32418920.54 (0.36 to 0.81)0.65 (0.43 to 0.98)0.51 (0.27 to 0.94)0.59 (0.31 to 1.12)
  • CVD, cardiovascular disease; NSAID, non-steroidal anti-inflammatory drug; OR, odds ratio.